Gentian Diagnostics ASA (OSL:GENT)

Norway flag Norway · Delayed Price · Currency is NOK
55.60
-0.80 (-1.42%)
Jul 16, 2025, 11:31 AM CET
-0.71%
Market Cap 869.82M
Revenue (ttm) 163.38M
Net Income (ttm) 42.19M
Shares Out 15.42M
EPS (ttm) 2.65
PE Ratio 21.32
Forward PE 34.99
Dividend 0.40 (0.72%)
Ex-Dividend Date May 7, 2025
Volume 1,671
Average Volume 19,389
Open 55.80
Previous Close 56.40
Day's Range 55.60 - 55.80
52-Week Range 37.00 - 65.80
Beta 0.36
RSI 36.24
Earnings Date Jul 10, 2025

About Gentian Diagnostics ASA

Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe. The company offers in-vitro diagnostic reagents for clinical chemistry analyzers, such as Gentian Circulating Calprotectin Immunoassay, a turbidimetric assay used for the measurement of calprotectin in plasma and serum for detection and assessment of inflammation; Gentian Cystatin C Immunoassay test kit, a GFR marker for the diagnosis and therapeutic control of renal function and chro... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2001
Employees 63
Stock Exchange Oslo Børs
Ticker Symbol GENT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.